Navigation Links
EAU Technologies Announces New Chairman of the Board and Board Leadership
Date:11/7/2007

Technology (EOW Technology marketed as Empowered Water(TM)) and other complementary technologies with applications in diverse industries. EAU's water-based and non-toxic (at application concentration, the solutions are non-toxic to humans and live animals). EOW Technology may replace many of the traditional methods now used to clean, disinfect and nourish in large industries such as agriculture and food processing. EAU has solutions for existing bacteria, virus and mold proliferation threats. EAU continues to add innovative and efficacious products that offer a systemic approach to pathogen elimination in food processing plants and related industries, thereby producing safer foods while protecting the environment through "Green Technology." Terms like "green", "natural", "non-toxic" and "organic" based on our NAMSA studies that show no toxicity or cytotoxicity at levels as high as 70 ppm of HOCl. EAU uses only water, food grade electrolytes and electricity to create all of its solutions. The active ingredients in the solutions EAU creates through electrolysis are GRAS (generally regarded as safe) approved. Please visit our website and sign up to be emailed our press releases and public announcements. http://www.eau-x.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward- looking statements may include without limitation, our expectations about the growth and the potential for the company, and Mr. Bradley's abilities to lead the company
'/>"/>

SOURCE EAU Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Th...onsistent procedures to allow the public to,see ex...ished today in the,Federal Register http://edocke...will ensure that the best and latest available evi... risk assessments for health,standards regulating ...
(Date:8/29/2008)...iation may have caused chromosomal change that rai... FRIDAY, Aug. 29 (HealthDay News) -- Some Japanese...in Hiroshima and Nagasaki experienced key genetic ...of thyroid cancer, new research indicates. , Pa...o a particular genetic mutation involving the so-c...
(Date:8/29/2008)... LEEDS, England, August 29 /PRNewswire/ --, - MYA...ce for Recent,Big Brother Stars but the big Questi...as, mirrors all around and being on national,telev...ct on how you feel,about the way you look. For man... a reality. Upon leaving the house contestants may...
(Date:8/29/2008)... Dr. Milton Owens and the Co... Southern California to provide protection for cas...on, and the Hispanic community is benefiting. , ...ust 29, 2008 -- Dr. Milton Owens and the Coastal C...rn California to provide protection for cash payin...
Breaking Medicine News(10 mins):Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:MYA Makes Big Brother Stars Amazing! 2Health News:MYA Makes Big Brother Stars Amazing! 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2
...result of the bird flu outbreak in the country. Th...ndustry to a very large extent//. Both the Governm...r citizens not to make tourist visits to Turkey. T...tourists. The outbreak in the country has badly af...
...ple suffering from stress and other related sympto...Westminster studied the stress levels // of 28 par...The researcher tells us that saliva cortisol level...one’s stress level. The participant’s saliva cort...
...ombining the two does wonders. In the same vein Ma... (MOH) China has announced that they // will pub...n. In his clarification and statement, "Last year,...AIDS) and the World Health Organization (WHO) join...
...na State University have successfully produced Pla...were able to produce vaccines from bioengineered /...nea pigs which were exposed to pneumonic plague ba...trial of the new vaccine in human to study the eff...
Other Medicine News:Health News:Tobacco plant based Vaccine against Plague 2
(Date:8/27/2008)...art Center at The Children,s Hospital at, Montef...ge of Care and Specialty...Team Treats Every Heart Condition, NEW YORK, Aug....ital at,Montefiore (CHAM) is bringing the medical ...Bronx, following the recent approval of its,transp...
(Date:8/26/2008)...re/ -- Semafore Pharmaceuticals Inc.,announced dat...on Targeted,Therapies in Cancer in Washington, D.C...ascular-targeted PI3 kinase (PI3K) inhibitor SF112... is part of a very powerful pathway, the PI3/AKT /...ole in cancer. Studies have shown that by,inhibiti...
(Date:8/26/2008)...ire/ -- Cambridge Research &,Instrumentation, Inc.... In,Vivo Imaging System. The new system incorporat...mes the entry-level instrument of choice for in,vi...scom.com/cgi-bin/prnh/20080826/NETU054 ), FLEX t...CRi,s unique,solid-state tunable optics that for t...
(Date:8/25/2008)...n Menstrual Blood May Offer Long-Lasting ...OLDSMAR, Fla., Aug. 25 /- Time. It is...that there never seems to be enough,of it. And the...thing just,for herself usually pales in comparison...as led many women in need of quality time to seek ...
Breaking Medicine Technology:Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2No Change in Cancer Care Race Gap Since 1990s 9138 1No Change in Cancer Care Race Gap Since 1990s 9138 2Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition 9134 1Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition 9134 2Aida Receives Chinese Government Innovation Award 2476 1Aida Receives Chinese Government Innovation Award 2476 2Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 1Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 2Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 3Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 4Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 5
...nse Webster is the source for a complete line of d...mapping - all with the quality, reliability and pr...eader in catheter technology. All of our coronary ...tructed to help minimize the frustration and exces...
A-Focus I & II Catheters. A-Focus steerable atrial mapping catheter. Available in 10, 12, 14 and 20 electrode configurations. (Shown with 14 electrodes).
Mennen Medical offers patient monitoring products for hospital based settings requiring high acuity and medium acuity monitoring. The Envoy patient monitor is Mennens premier monitoring product. The
...IS PhysioLog Hemodynamic Monitoring and Data Manag...m for the cath lab, integrating complete functiona...m analysis , Data collection , Inventory contr... , Procedural reporting ,Data collection ...
Medicine Products: